What is the ticker symbol for Compass Therapeutics?

Compass Therapeutics trades under the ticker CMPX on NASDAQ.

What sector does Compass Therapeutics operate in?

Compass Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CMPX in a portfolio?

PortView shows CMPX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Compass Therapeutics (CMPX) Stock Analysis

NASDAQHealthcareBiotechnology

$2.32+0.43%

1-year price historyRange $1.67 – $6.69

52-week range$2.32

$1.61$6.88

What Compass Therapeutics does

Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.

Key metrics

Market cap

$417.80M

P/E (TTM)

-5.80

EPS (TTM)

$-0.40

Beta

0.82

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.19

200-day avg

$4.01

52-week high

$6.88

52-week low

$1.61

CEO

Thomas J. Schuetz

ETFs linked to CMPX

Broad-market and Healthcare sector ETFs an investor holding Compass Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CMPX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CMPX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Compass Therapeutics?: Compass Therapeutics trades under the ticker CMPX on NASDAQ.
Which exchange is CMPX listed on?: CMPX is listed on NASDAQ.
What sector does Compass Therapeutics operate in?: Compass Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CMPX in a portfolio?: PortView shows CMPX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.